2025-04-18T05:32:00-07:00 2023-12-31 262176601 EASY OFFICE DBA JITASA 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 990 2023-01-01 843817744 CENTER FOR CONTEMPORARY SCIENCES INC CENT 4733659693 9841 WASHINGTON BLVD 200 GAITHERSBURG MD 20878 DAMON L ISAACS BOARD OF DIRECTORS CHAIR 2025-04-18 1 1 JEREMY CORK P01544850 2082874777 2025-04-18 2023 2025-03-06 01:10:19Z AYSHA AKHTAR 9841 WASHINGTON BLVD 200 GAITHERSBURG MD 20878 260007 0 X contemporarysciences.org X 2019 MA USING SCIENCE TO DO GOOD. TO UNLOCK THE POWER OF SCIENCE TO FIND SOLUTIONS THAT IMPROVE THE HEALTH AND WELLBEING OF HUMANS, ANIMALS, AND THE PLANET. 4 4 5 4 0 0 244579 254111 0 0 0 0 0 5896 244579 260007 0 0 0 0 455688 433552 30809 0 65896 59522 138184 546019 571736 -301440 -311729 789334 465250 36992 24637 752342 440613 USING SCIENCE TO DO GOOD. TO UNLOCK THE POWER OF SCIENCE TO FIND SOLUTIONS THAT IMPROVE THE HEALTH AND WELLBEING OF HUMANS, ANIMALS, AND THE PLANET. 0 0 347392 0 0 ADVOCACY/POLICY: CCS LEADS TARGETED ADVOCACY EFFORTS TO SHAPE LARGE-SCALE NATIONAL HEALTH POLICIES AND IMPROVE STATEWIDE LEGISLATIVE AGENDAS. THROUGH ENGAGEMENT WITH KEY STAKEHOLDERS ACROSS INDUSTRY, ACADEMIA, MEDICAL AGENCIES, AND VARIOUS BRANCHES OF THE U.S. GOVERNMENT, WE SEEK TO TRANSFORM MEDICAL RESEARCH PRACTICES, ADVANCE SUSTAINABILITY INITIATIVES, AND PROMOTE PANDEMIC PREVENTION MEASURES. WE RELY ON EVIDENCE-BASED SCIENCE TO MODERNIZE PUBLIC POLICY AND EXECUTE ADVOCACY CAMPAIGNS THAT BENEFIT SOCIETY, PROTECT THE ENVIRONMENT, AND PROMOTE ANIMAL WELFARE. SCIENCES/TECHNOLOGY: CCS WORKS ON MULTIPLE FRONTS TO SHIFT THE EXISTING PARADIGM IN MEDICAL RESEARCH AND OTHER HEALTH-IMPACTING AREAS. THE CCS INVESTOR SUMMIT IS A ONE-OF-A-KIND BUSINESS DEVELOPMENT EVENT THAT CONNECTS INNOVATORS, INVESTORS, RESEARCHERS, AND VENTURE PHILANTHROPISTS TO SUPPORT MODERN TECHNOLOGIES IN THE EMERGING FIELD OF HUMAN-RELEVANT ALTERNATIVES TO ANIMAL EXPERIMENTATION. THE CCS INNOVATION CIRCLE BRINGS TOGETHER PARTNERS ACROSS VARIOUS SECTORS TO PROVIDE A UNIFIED VOICE FOR THE SCIENTIFIC COMMUNITY AND POLICYMAKERS, FOSTERING THE DISCOVERY, DEVELOPMENT, REFINEMENT, AND ADOPTION OF THE BEST SCIENTIFIC INNOVATIONS THAT CAN REPLACE INEFFECTIVE ANIMAL TESTING. THREATS: CCS PROVIDES SCIENTIFIC PERSPECTIVES ON THE HUMAN HEALTH THREATS POSED BY WILDLIFE TRADE AND FACTORY FARMING. WE ENGAGE WITH HEALTH AGENCIES AND OTHER STAKEHOLDERS IN SUPPORT OF PROGRESSIVE INITIATIVES AIMED AT MITIGATING THESE RISKS. EDUCATION/TRAINING: CCS SERVES AS A TRUSTED RESOURCE FOR EDUCATING STAKEHOLDERS, INCLUDING ACADEMICS, POLICYMAKERS, AND STUDENTS, ABOUT PANDEMICS, HUMAN HEALTH THREATS, AND THE LATEST BREAKTHROUGHS IN SCIENCE AND TECHNOLOGY-SUCH AS HUMAN-RELEVANT TESTING METHODS. OUR IN-HOUSE FELLOWSHIP AND INTERNSHIP PROGRAM ATTRACTS STUDENTS AND EMERGING PROFESSIONALS LOOKING TO HONE THEIR SKILLS IN A RIGOROUS, CROSS-DISCIPLINARY ENVIRONMENT. ADDITIONALLY, CCS REGULARLY PRODUCES FREE PUBLIC EVENTS, INFORMATIVE DATABASES, AND EDUCATIONAL MATERIALS. THROUGH THESE INITIATIVES, WE STRIVE TO RAISE PUBLIC AWARENESS, DRIVE GENERATIONAL CHANGE, AND DEVELOP A NETWORK OF INFORMED PROFESSIONALS EQUIPPED WITH THE KNOWLEDGE, TOOLS, AND RESOURCES NEEDED TO TACKLE SOME OF THE MOST PRESSING HEALTH CHALLENGES OF OUR TIME. 0 0 0 347392 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 0 1 5 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA MD X X DAMON ISAACS 4733659693 9841 WASHINGTON BLVD 200 GAITHERSBURG MD 20878 AYSHA AKHTAR CEO 40 X 144250 0 0 DAMON ISAACS BOARD CHAIR/TREASURER 6 X X 368 0 0 PAMELA SPENCER TREASURER - RESIGNED JULY 2023 1 X X 0 0 0 JESSICA MCDONOUGH BOARD CLERK 3 X X 0 0 0 BRIAN COOLEY BOARD MEMBER 2 X 0 0 0 WARREN CASEY BOARD MEMBER 1 X 0 0 0 144618 0 0 1 0 0 0 0 0 0 0 0 2014 252097 0 254111 0 0 0 0 0 0 MISCELLANEOUS REVENUE 900099 5896 5896 0 0 0 0 0 0 5896 260007 5896 0 0 144617 96981 25739 21897 222670 149350 39520 33800 37600 27764 5193 4643 28665 18935 5289 4441 5049 5049 27453 27453 42956 26899 16057 554 454 100 3531 3139 392 3147 343 2283 521 4857 3776 1081 18428 18428 6851 6851 MISCELLANEOUS EXPENSES 22399 21714 685 0 DUES AND SUBSCRIPTIONS 2959 1630 1227 102 571736 347392 158448 65896 732731 444359 21214 5758 9688 69173 57970 29631 11203 789334 465250 36992 24637 36992 24637 X 722294 440613 30048 0 752342 440613 789334 465250 -311729 0 0 0 0 0 X 1 X 0 0 0 X 670343 361219 244580 254111 1530253 0 670343 361219 244580 254111 1530253 69395 1460858 1530253 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 0 0 0 0 9242 8355 887 0 59931 49615 10316 11203 Form 990, Part VI, Section B, Line 11b THE 990 WILL BE REVIEWED BY MANAGEMENT AND A COPY WILL BE PROVIDED TO ALL BOARD MEMBERS PRIOR TO FILING WITH THE IRS. Form 990, Part VI, Section B, Line 12c THE CONFLICT OF INTEREST POLICY IS CIRCULATED TO ANY DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE TO DISCLOSE THE EXISTENCE OF ANY FINANCIAL INTEREST. Form 990, Part VI, Section B, Line 15 THE BOARD OF DIRECTORS WILL SET THE SALARY OF THE CEO/EXECUTIVE DIRECTOR. Form 990, Part VI, Section C, Line 19 THE ORGANIZATION MAKES ITS DOCUMENTS AVAILABLE UPON REQUEST. 990 FORMS ARE AVAILABLE VIA WEBSITES IRS.GOV AND GUIDESTAR.ORG.